EQT X to Acquire Adalvo (B2B Generic Drug Dossiers)

EQT X to Acquire Adevinta's Spanish Online Classifieds Businesses

July 21, 2025

E-Commerce

EQT X has agreed to acquire Adevinta's Spanish operations ("Adevinta Spain"), which include major Spanish online classifieds platforms such as Coches.net, InfoJobs, Milanuncios, Fotocasa, and Habitaclia. The transaction is expected to close in Q1 2026, subject to customary approvals and conditions.

Novo Holdings Acquires Ellab from EQT Private Equity

June 21, 2023

Medical Devices

Novo Holdings A/S has agreed to acquire Ellab from EQT Mid Market Europe (EQT Private Equity); the deal was announced in June and subsequently completed following regulatory approvals. Headquartered in Hillerød, Denmark, Ellab is a provider of validation and monitoring hardware, software and services for the biotech and pharmaceutical industries; the Lundbeck Foundation has also agreed to acquire a significant minority stake.

TriNetX Acquires Advera Health Analytics

January 21, 2022

Data & Analytics

TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.

Aditxt Signs Share Exchange Agreement to Acquire AiPharma Global Holdings

December 28, 2021

Healthcare Services

Aditxt (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC (AiPharma Global) in a two-step transaction involving an initial closing and a secondary closing, subject to conditions including regulatory, board, shareholder, and Nasdaq approvals. The deal would give Aditxt 9.5% of AiPharma at the initial closing and the remaining 90.5% at the secondary closing, with cash payments and Aditxt share issuance at each step.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.

EQT VIII to Acquire Majority Interest in Aldevron

July 31, 2019

Biotechnology

EQT VIII has entered into an agreement to acquire a majority interest in Aldevron, a Fargo-based global supplier of plasmid DNA and other biologics, with founders, management and TA Associates retaining minority stakes. EQT will support Aldevron's growth through investments in production capacity, R&D and international expansion as the company continues to serve the gene therapy and broader biopharma markets.